Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 141

1.

Use of florbetapir-PET for imaging beta-amyloid pathology.

Clark CM, Schneider JA, Bedell BJ, Beach TG, Bilker WB, Mintun MA, Pontecorvo MJ, Hefti F, Carpenter AP, Flitter ML, Krautkramer MJ, Kung HF, Coleman RE, Doraiswamy PM, Fleisher AS, Sabbagh MN, Sadowsky CH, Reiman EP, Zehntner SP, Skovronsky DM; AV45-A07 Study Group.

JAMA. 2011 Jan 19;305(3):275-83. doi: 10.1001/jama.2010.2008. Erratum in: JAMA. 2011 Mar 16;305(11):1096. Reiman, P Eric M [corrected to Reiman, Eric M].

PMID:
21245183
[PubMed - indexed for MEDLINE]
2.

Florbetapir-PET imaging and postmortem beta-amyloid pathology.

Carome M, Wolfe S.

JAMA. 2011 May 11;305(18):1857; author reply 1857-8. doi: 10.1001/jama.2011.579. No abstract available.

PMID:
21558513
[PubMed - indexed for MEDLINE]
3.

Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.

Lister-James J, Pontecorvo MJ, Clark C, Joshi AD, Mintun MA, Zhang W, Lim N, Zhuang Z, Golding G, Choi SR, Benedum TE, Kennedy P, Hefti F, Carpenter AP, Kung HF, Skovronsky DM.

Semin Nucl Med. 2011 Jul;41(4):300-4. doi: 10.1053/j.semnuclmed.2011.03.001.

PMID:
21624563
[PubMed - indexed for MEDLINE]
4.

[Amyloid PET imaging with [18F]AV-45].

Tateno A, Okubo Y.

Nihon Rinsho. 2011 Oct;69 Suppl 8:561-4. Japanese. No abstract available.

PMID:
22787851
[PubMed - indexed for MEDLINE]
5.

Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.

Vallabhajosula S.

Semin Nucl Med. 2011 Jul;41(4):283-99. doi: 10.1053/j.semnuclmed.2011.02.005. Review.

PMID:
21624562
[PubMed - indexed for MEDLINE]
6.

Beta amyloid imaging with positron emission tomography (PET) for evaluation of suspected Alzheimer's disease or other causes of cognitive decline.

[No authors listed]

Technol Eval Cent Assess Program Exec Summ. 2013 Feb;27(5):1-4. No abstract available.

PMID:
23589929
[PubMed - indexed for MEDLINE]
7.

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

Okamura N, Yanai K.

IDrugs. 2010 Dec;13(12):890-9. Review.

PMID:
21154149
[PubMed - indexed for MEDLINE]
8.

Brain amyloid imaging--FDA approval of florbetapir F18 injection.

Yang L, Rieves D, Ganley C.

N Engl J Med. 2012 Sep 6;367(10):885-7. doi: 10.1056/NEJMp1208061. No abstract available.

PMID:
22931256
[PubMed - indexed for MEDLINE]
Free Article
9.

An imaging agent for amyloid.

[No authors listed]

Med Lett Drugs Ther. 2012 Jul 9;54(1394):54-5. No abstract available.

PMID:
22777304
[PubMed - indexed for MEDLINE]
10.

Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.

Doraiswamy PM, Sperling RA, Coleman RE, Johnson KA, Reiman EM, Davis MD, Grundman M, Sabbagh MN, Sadowsky CH, Fleisher AS, Carpenter A, Clark CM, Joshi AD, Mintun MA, Skovronsky DM, Pontecorvo MJ; AV45-A11 Study Group.

Neurology. 2012 Oct 16;79(16):1636-44. doi: 10.1212/WNL.0b013e3182661f74. Epub 2012 Jul 11.

PMID:
22786606
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography.

Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE.

J Neurol Neurosurg Psychiatry. 2012 Sep;83(9):923-6. doi: 10.1136/jnnp-2012-302548. Epub 2012 Jul 11.

PMID:
22791901
[PubMed - indexed for MEDLINE]
12.

Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue.

Choi SR, Schneider JA, Bennett DA, Beach TG, Bedell BJ, Zehntner SP, Krautkramer MJ, Kung HF, Skovronsky DM, Hefti F, Clark CM.

Alzheimer Dis Assoc Disord. 2012 Jan-Mar;26(1):8-16. doi: 10.1097/WAD.0b013e31821300bc.

PMID:
22354138
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Joshi AD, Pontecorvo MJ, Clark CM, Carpenter AP, Jennings DL, Sadowsky CH, Adler LP, Kovnat KD, Seibyl JP, Arora A, Saha K, Burns JD, Lowrey MJ, Mintun MA, Skovronsky DM; Florbetapir F 18 Study Investigators.

J Nucl Med. 2012 Mar;53(3):378-84. doi: 10.2967/jnumed.111.090340. Epub 2012 Feb 13.

PMID:
22331215
[PubMed - indexed for MEDLINE]
Free Article
14.

Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.

Fleisher AS, Chen K, Liu X, Roontiva A, Thiyyagura P, Ayutyanont N, Joshi AD, Clark CM, Mintun MA, Pontecorvo MJ, Doraiswamy PM, Johnson KA, Skovronsky DM, Reiman EM.

Arch Neurol. 2011 Nov;68(11):1404-11. doi: 10.1001/archneurol.2011.150. Epub 2011 Jul 11.

PMID:
21747008
[PubMed - indexed for MEDLINE]
15.

GMP-compliant automated synthesis of [(18)F]AV-45 (Florbetapir F 18) for imaging beta-amyloid plaques in human brain.

Yao CH, Lin KJ, Weng CC, Hsiao IT, Ting YS, Yen TC, Jan TR, Skovronsky D, Kung MP, Wey SP.

Appl Radiat Isot. 2010 Dec;68(12):2293-7. doi: 10.1016/j.apradiso.2010.07.001. Epub 2010 Jul 7.

PMID:
20638295
[PubMed - indexed for MEDLINE]
16.

Florbetapir F 18 for brain imaging of β-amyloid plaques.

Romano M, Buratti E.

Drugs Today (Barc). 2013 Mar;49(3):181-93. doi: 10.1358/dot.2013.49.3.1937428.

PMID:
23527322
[PubMed - indexed for MEDLINE]
17.

Initial clinical comparison of 18F-florbetapir and 18F-FDG PET in patients with Alzheimer disease and controls.

Newberg AB, Arnold SE, Wintering N, Rovner BW, Alavi A.

J Nucl Med. 2012 Jun;53(6):902-7. doi: 10.2967/jnumed.111.099606. Epub 2012 May 10.

PMID:
22577238
[PubMed - indexed for MEDLINE]
Free Article
18.

Whole-body biodistribution and brain PET imaging with [18F]AV-45, a novel amyloid imaging agent--a pilot study.

Lin KJ, Hsu WC, Hsiao IT, Wey SP, Jin LW, Skovronsky D, Wai YY, Chang HP, Lo CW, Yao CH, Yen TC, Kung MP.

Nucl Med Biol. 2010 May;37(4):497-508. doi: 10.1016/j.nucmedbio.2010.02.003. Epub 2010 Apr 7.

PMID:
20447562
[PubMed - indexed for MEDLINE]
19.

Using PET with 18F-AV-45 (florbetapir) to quantify brain amyloid load in a clinical environment.

Camus V, Payoux P, Barré L, Desgranges B, Voisin T, Tauber C, La Joie R, Tafani M, Hommet C, Chételat G, Mondon K, de La Sayette V, Cottier JP, Beaufils E, Ribeiro MJ, Gissot V, Vierron E, Vercouillie J, Vellas B, Eustache F, Guilloteau D.

Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):621-31. doi: 10.1007/s00259-011-2021-8. Epub 2012 Jan 18.

PMID:
22252372
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Radioactive agent approved as part of Alzheimer disease workup.

Thompson CA.

Am J Health Syst Pharm. 2012 May 15;69(10):818. doi: 10.2146/news120033. No abstract available.

PMID:
22555074
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk